Tandem Diabetes Care Inc’s recently made public that its EVP & Chief Operating Officer Kyrillos Jean-Claude acquired Company’s shares for reported $0.19 million on Mar 07 ’25. In the deal valued at $18.12 per share,10,538 shares were bought. As a result of this transaction, Kyrillos Jean-Claude now holds 10,538 shares worth roughly $0.16 million.
Then, BLICKENSTAFF KIM D sold 30,000 shares, generating $941,400 in total proceeds. Upon selling the shares at $31.38, the Director now owns 165,190 shares.
Before that, BLICKENSTAFF KIM D sold 10,000 shares. Tandem Diabetes Care Inc shares valued at $300,000 were divested by the Director at a price of $30.00 per share. As a result of the transaction, BLICKENSTAFF KIM D now holds 195,190 shares, worth roughly $3.01 million.
Citigroup downgraded its Tandem Diabetes Care Inc [TNDM] rating to a Sell from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in mid June with a ‘”a Hold”‘ rating. Mizuho began covering TNDM with “Neutral” recommendation on April 10, 2025. Morgan Stanley revised its rating on March 05, 2025. It rated TNDM as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of TNDM
On Friday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock fall -1.16% to $15.4. Over the last five days, the stock has lost -3.08%. Tandem Diabetes Care Inc shares have fallen nearly -57.66% since the year began. Nevertheless, the stocks have fallen -57.25% over the past one year.
How much short interest is there in Tandem Diabetes Care Inc?
A steep rise in short interest was recorded in Tandem Diabetes Care Inc stocks on 2025-07-15, growing by 1.27 million shares to a total of 10.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 8.82 million shares. There was a rise of 12.6%, which implies that there is a positive sentiment for the stock.
